Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 10 Projects
Project # Contact PI Funding Organization Fiscal Year
Testing low-dose efavirenz treatment for Alzheimer’s disease: a phase 1b dosing, target-engagement and exploratory biomarker study.
ADDF-48 SCHELTENS, PHILIP Alzheimer's Drug Discovery Foundation 2021
Blood-based markers for Alzheimer’s pathology in cognitively healthy centenarians: revealing mechanisms of resistance and resilience
A2021031S Henne Holstege BrightFocus Foundation 2021
A Phase IIa Trial to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of TW001 in Alzheimer Patients
GC-2013807 van der Geest, Ronald Alzheimer's Drug Discovery Foundation 2018
The Clinical Relevance of Cortical Cerebral Microinfarcts in Degenerative Brain Pathology such as Alzheimer’s Disease
A2018165F Hilal, Saima BrightFocus Foundation 2018
Influence of Atherosclerosis on Brain Structure, Cognitive Function, and Dementia
A2017424F Bos, Daniel BrightFocus Foundation 2017
Project Itwin
EUJPND-Stichting ALS-Multiple PI-1746 Multiple PI Stichting ALS 2016
Novel diagnostic CSF biomarkers for pathological subtypes of FTD
20141204-Teunissen-2014 Teunissen, Charlotte Alzheimer's Drug Discovery Foundation 2014
Tau, Abeta and network degeneration in Alzheimer’s disease
A2014083F OSSENKOPPELE, RIK BrightFocus Foundation 2014
Identification of novel discriminatory CSF biomarkers for different FTD subtypes by proteomics
20111106 AFTD-Teunissen-2011 Teunissen, Charlotte Alzheimer's Drug Discovery Foundation 2011
TDP-43 and tau as cerebrospinal fluid biomarkers to discriminate frontotemporal dementia subtypes
20101207 AFTD-Verbeek-2010 Verbeek, Marcel Alzheimer's Drug Discovery Foundation 2010